Insider Transactions in Q2 2021 at Nextgen Healthcare, Inc. (NXGN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2021
|
David A Metcalfe Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,248
-3.13%
|
$67,968
$16.69 P/Share
|
|
Jun 26
2021
|
James Robert Arnold Jr. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,946
-0.78%
|
$47,136
$16.69 P/Share
|
|
Jun 26
2021
|
Jeffrey D Linton EVP, General Counsel/Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,749
-3.91%
|
$43,984
$16.69 P/Share
|
|
Jun 03
2021
|
Mitchell Waters EVP, Commercial Growth |
SELL
Open market or private sale
|
Direct |
5,102
-3.81%
|
$86,734
$17.09 P/Share
|
|
Jun 01
2021
|
David Ahmadzai Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,060
-2.26%
|
$32,960
$16.59 P/Share
|
|
Jun 01
2021
|
Mitchell Waters EVP, Commercial Growth |
SELL
Payment of exercise price or tax liability
|
Direct |
2,198
-1.54%
|
$35,168
$16.59 P/Share
|
|
Jun 01
2021
|
Craig A. Barbarosh |
SELL
Open market or private sale
|
Direct |
9,000
-9.9%
|
$144,000
$16.56 P/Share
|
|
Apr 23
2021
|
John R Frantz CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
12,022
-2.74%
|
$216,396
$18.84 P/Share
|
|
Apr 12
2021
|
Craig A. Barbarosh |
SELL
Open market or private sale
|
Direct |
9,000
-9.0%
|
$162,000
$18.7 P/Share
|